Clinical Trial Update: Feasibility of Slow-paced Respiration Therapy for Treatment of a Symptom Cluster in Pulmonary Arterial Hypertension [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 study evaluating the feasibility of slow-paced respiration therapy for managing symptoms in pulmonary arterial hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Slow-paced Respiration Therapy

Snippet

Sponsor: University of Pennsylvania | Conditions: Pulmonary Arterial Hypertension | Phase 1, Phase 2 | Status: COMPLETED